Hemodiafiltration with online regeneration of the ultrafiltrate.

The concept of regeneration of dialysis fluids and of ultrafiltrate in particular has been recently revisited. Hemodiafiltration with online regeneration of the ultrafiltrate allows the concomitant infusion of sodium, calcium, and bicarbonate. Here, we studied the adsorptive characteristics of an integrated two-step sorbent system relative to different solutes present in the ultrafiltrate: sodium, calcium, phosphate, bicarbonate, uric acid, creatinine, and beta2-microglobulin. In vitro studies were performed in order to differentiate the relative roles for each sorbent (mineral-activated charcoal or hydrophobic resin) in adsorbing a given solute. Ex vivo studies were performed in order to evaluate the presence of cytokines (interleukin-1 beta and tumor necrosis factor-alpha), of cytokine (interleukin-1 beta and tumor necrosis factor-alpha)-inducing activities, and of the cytokine release in response to exogenous bacterial lipopolysaccharide by normal whole blood incubated with ultrafiltrate samples obtained at 15, 120, and 240 minutes after the start of treatment. The results of the present studies show the presence of immunomodulatory substances in the ultrafiltrate and the significant (P < 0.01) increase in the lipopolysaccharide-induced release of both interleukin-1 beta and tumor necrosis factor-alpha. The biological relevance of the ultrafiltrate and the possible relevance of the online, endogenous reinfusion are discussed.

[1]  R. Vanholder,et al.  Uremic Ultrafiltrate Inhibits Platelet-Activating Factor Synthesis , 1999, Blood Purification.

[2]  C. Ronco,et al.  Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.

[3]  D. Inthorn,et al.  Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. , 1995, Contributions to nephrology.

[4]  J. Cavaillon,et al.  C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. , 1987, Journal of immunology.

[5]  C. Ronco,et al.  Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  J. Winchester,et al.  Extracorporeal Blood Purification Techniques: Plasmapheresis and Hemoperfusion , 1996 .

[7]  R. Scandurra,et al.  Perfusion of uremic blood ultrafiltrate on uncoated charcoal. , 1989, Artificial organs.

[8]  I. Lundkvist,et al.  Uremic serum enhances scavenger receptor expression and activity in the human monocytic cell line U937. , 1997, Kidney international.

[9]  L. Minetti,et al.  Hemofiltration without substitution fluid: a physiological approach to renal replacement therapy , 1987 .

[10]  R. Vanholder,et al.  Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  W. van Biesen,et al.  The removal of uremic toxins. , 2000, Kidney international. Supplement.

[12]  P. Ghezzi,et al.  Adsorption in hemodialysis. , 2000, Kidney international. Supplement.

[13]  K. Berg,et al.  Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system. , 1980, Clinical nephrology.

[14]  P. Ghezzi,et al.  Use of the Ultrafiltrate Obtained in Two-Chamber (Pfd) Hemodiafiltration as Replacement Fluid. Experimental ex vivo and in Vitro Study , 1991, The International journal of artificial organs.

[15]  J. Lundahl,et al.  Dialysis-induced serum factors inhibit adherence of monocytes and granulocytes to adult human endothelial cells. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Vanholder,et al.  HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump. , 1997, Kidney international.

[17]  S. Cerutti,et al.  Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. , 1996, Kidney international.

[18]  M. Schrader,et al.  Composition of the peptide fraction in human blood plasma: database of circulating human peptides. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[19]  P. Ghezzi,et al.  Technical requirements for rapid high-efficiency therapy in uremic patients. Paired filtration-dialysis (PFD) with a two-chamber technique. , 1987, ASAIO transactions.

[20]  M. Bennish,et al.  Interleukin‐1β (IL‐1β), IL‐1 receptor antagonist, and TNFα production in whole blood , 1992 .